Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongste, J. C., Pijnenburg, M. W., Thomas, M., Price, D.
The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592
Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT
Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
Hudson, J., Cruickshank, M., Quinton, R., Aucott, L., Aceves Martins, M., Gillies, K., Bhasin, S., Snyder, P., Ellenberg, S., Grossmann, M., Travison, T., Gianatti, E., van der Schouw, Y., Emmelot Vonk, M., Gilaty, E., Hackett, G., Ramchandran, S., Svartberg, J., Hildreth, K., Groti Antoniv, K., Brock, G., Tenover, L., Meng, H., Ho Chee Kong, C., Shen Tan, W., Mark, L., Ross, R., Schwartz, R., Manson, P., Roberts, S., Skicsage Andersen, M., Velling, L., Hernández, R. A., Oliver, N., Wu, F. C. W., Dhillo, W. S., Bhattacharya, S., Brazzelli, M., Jayasena, C. N.
The Lancet Healthy Longevity, vol. 3, no. 6, pp. e381–393